The Convergence of Life Science & Technology report
In this edition of our Life Sciences 2030 series, we worked with YouGov to track the growing relationship between science and technology, and the momentum of their convergence.
In the last two years, we have seen social media giant, Meta, use artificial intelligence (AI) to predict the structures of some 600 million proteins, NVIDIA, a gaming chip company launch Clara Discovery for drug discovery and Alphabet raise $1bn of investment into Verily, its life science offshoot.
This big tech movement into life sciences is the tip of the iceberg with a depth of specialist companies across the technology sectors raising finance and making real differences in potential health outcomes globally, not in some distant future, but in many cases over the next couple of years.
In our latest piece of work, we asked R&D managers at many of the UK’s leading life sciences research businesses what the future holds in order to understand the implications for location and property specific demand.
Written in association with
Download the report
Privacy notice
Get in touch
Max Bryan
Partner, Head of Laboratory & Office Agency
Life Sciences 2030
We are witnessing an evolution of the life science sector both in the UK and internationally. Not only is the sector expanding rapidly but scientific developments are facilitating new techniques and product outputs.
Download our other Life Sciences reportsScience and Technology
We've been the number one advisor to the science and technology sector in the UK for 50 years – ever since we helped Trinity College with the creation of Cambridge Science Park in the early 1970s.
